NASDAQ:BTCY Biotricity (BTCY) Stock Price, News & Analysis $0.54 -0.03 (-5.26%) As of 03:34 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOptions ChainSEC FilingsTrendsBuy This Stock About Biotricity Stock (NASDAQ:BTCY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Biotricity alerts:Sign Up Key Stats Today's Range$0.54▼$0.6450-Day Range$0.36▼$0.6552-Week Range$0.19▼$0.83Volume19,072 shsAverage Volume38,059 shsMarket Capitalization$13.45 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California. Read More Receive BTCY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BTCY Stock News HeadlinesCritical Comparison: Biotricity (NASDAQ:BTCY) vs. Retractable Technologies (NYSE:RVP)August 28 at 2:15 AM | americanbankingnews.comBiotricity reports Q1 EPS (3c) vs (49c) last yearAugust 14, 2025 | msn.comINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.August 29 at 2:00 AM | Traders Agency (Ad)Biotricity Reinforces Growth Trajectory, Kicking Off Fiscal 2026 with Strong First Quarter Results Featuring Revenue Growth, Positive EBITDA and Improved MarginsAugust 14, 2025 | globenewswire.comBiotricity to Host Fiscal 2026 First Quarter Financial Results and Business Update Call on August 14thAugust 12, 2025 | globenewswire.comBiotricity, Inc. (BTCY) Q4 2025 Earnings Conference Call TranscriptJuly 18, 2025 | seekingalpha.comBiotricity Inc.: Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability ...July 17, 2025 | finanznachrichten.deBiotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18thJuly 15, 2025 | globenewswire.comSee More Headlines BTCY Stock Analysis - Frequently Asked Questions How have BTCY shares performed this year? Biotricity's stock was trading at $0.2899 at the beginning of 2025. Since then, BTCY shares have increased by 86.3% and is now trading at $0.54. How were Biotricity's earnings last quarter? Biotricity, Inc. (NASDAQ:BTCY) released its quarterly earnings results on Thursday, June, 27th. The company reported ($0.47) earnings per share for the quarter, missing the consensus estimate of ($0.36) by $0.11. The business had revenue of $3.18 million for the quarter, compared to the consensus estimate of $3.20 million. When did Biotricity IPO? Biotricity (BTCY) raised $15 million in an initial public offering on Thursday, August 26th 2021. The company issued 5,000,000 shares at a price of $3.00 per share. H.C. Wainwright & Co. served as the underwriter for the IPO. How do I buy shares of Biotricity? Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Biotricity own? Based on aggregate information from My MarketBeat watchlists, some other companies that Biotricity investors own include Transdigm Group (TDG), Taiwan Semiconductor Manufacturing (TSM), Wix.com (WIX), Datadog (DDOG), Quanta Services (PWR), PayPal (PYPL) and Royal Caribbean Cruises (RCL). Company Calendar Last Earnings6/27/2024Today8/29/2025Next Earnings (Estimated)11/13/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:BTCY CIK1630113 Webwww.biotricity.com Phone(800) 590-4155FaxN/AEmployees40Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.21) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$14.09 million Net Margins-80.42% Pretax Margin-80.42% Return on EquityN/A Return on Assets-188.47% Debt Debt-to-Equity RatioN/A Current Ratio0.23 Quick Ratio0.10 Sales & Book Value Annual Sales$12.06 million Price / Sales1.16 Cash FlowN/A Price / Cash FlowN/A Book Value($1.30) per share Price / Book-0.43Miscellaneous Outstanding Shares24,912,000Free Float22,075,000Market Cap$14.04 million OptionableOptionable Beta1.12 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:BTCY) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotricity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotricity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.